Caresyntax Raises Additional $30M; Brings Series C To $130M


Caresyntax, a Boston WA-based digital surgery platform, raised an additional $30M which brought total Series C to $130M.

This round was led by PFM Health Sciences, with participation from funds and accounts managed by BlackRock, as well as ProAssurance, Harmonix, and existing investors such as the Relyens Group and IPF Partners. The first stage announced in April 2021 also included investments from Optum Ventures, Intel Capital, Lauxera Capital Partners, Vesalius Biocapital III, Arno Capital, Rezayat Investments, and Surgical.AI.

The company intends to use the funds to continue developing its platform as well as advance new data solutions that support value-based care providers.

Founded by entrepreneurs Dennis Kogan and Björn von Siemens, Caresyntax provides a digital surgery platform that delivers actionable insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around the OR.

The digital surgery platform uses proprietary software and artificial intelligence to analyze large volumes of real-world data in and around the operating room to deliver insights that can be used immediately by the care team and longer-term by a variety of critical stakeholders, including surgeons, to assess and improve care. Caresyntax also offers virtual, real-time access to outside experts, such as medical school instructors or medical device representatives, through its digital platform.

The software is used in more than 4,000 operating rooms worldwide and supports surgical teams in over two million procedures per year.